MUSELLA, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 2.847
AS - Asia 2.004
EU - Europa 545
SA - Sud America 225
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 30
OC - Oceania 6
Totale 5.700
Nazione #
US - Stati Uniti d'America 2.571
SG - Singapore 553
CN - Cina 542
TR - Turchia 480
IT - Italia 339
CA - Canada 252
VN - Vietnam 171
BR - Brasile 168
HK - Hong Kong 64
DE - Germania 54
PK - Pakistan 41
EU - Europa 28
IL - Israele 28
IN - India 26
GB - Regno Unito 25
AR - Argentina 19
FI - Finlandia 18
BD - Bangladesh 17
IQ - Iraq 14
RU - Federazione Russa 14
ID - Indonesia 13
MX - Messico 13
NL - Olanda 13
SC - Seychelles 13
ES - Italia 12
JP - Giappone 12
IE - Irlanda 11
PL - Polonia 10
SE - Svezia 10
EC - Ecuador 9
FR - Francia 9
ZA - Sudafrica 9
CL - Cile 8
CO - Colombia 7
UA - Ucraina 7
VE - Venezuela 7
SA - Arabia Saudita 6
UZ - Uzbekistan 6
AU - Australia 5
EG - Egitto 5
MA - Marocco 5
NP - Nepal 5
BO - Bolivia 4
CH - Svizzera 4
KR - Corea 4
PH - Filippine 4
IR - Iran 3
JO - Giordania 3
LT - Lituania 3
RO - Romania 3
TN - Tunisia 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
JM - Giamaica 2
KW - Kuwait 2
RS - Serbia 2
TH - Thailandia 2
AM - Armenia 1
AZ - Azerbaigian 1
BE - Belgio 1
BF - Burkina Faso 1
BG - Bulgaria 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
MD - Moldavia 1
ML - Mali 1
MR - Mauritania 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 5.700
Città #
Dallas 514
San Mateo 448
Kocaeli 401
San Jose 367
Toronto 228
Ashburn 224
Singapore 146
Rome 144
Beijing 134
Santa Clara 113
Wilmington 113
Houston 84
Lawrence 78
Princeton 78
Ho Chi Minh City 63
Hong Kong 59
Chandler 54
Los Angeles 43
Hanoi 42
Shanghai 41
Islamabad 36
Chicago 25
Netanya 25
Guangzhou 23
Frankfurt am Main 22
Seattle 19
São Paulo 19
The Dalles 19
Fairfield 18
Woodbridge 16
Columbus 15
Shenzhen 14
New York 13
Brooklyn 12
Tokyo 10
Turku 10
West Jordan 10
Da Nang 9
Falls Church 9
Milan 9
Boston 8
Cambridge 8
Council Bluffs 8
Helsinki 8
London 8
Warsaw 8
Amsterdam 7
Chennai 7
Jiaxing 7
Mexico City 7
Atlanta 6
Johannesburg 6
Montreal 6
Rui'an 6
San Francisco 6
Wuxi 6
Ankara 5
Boardman 5
Las Vegas 5
Salvador 5
Stockholm 5
Tashkent 5
Viggiù 5
Xi'an 5
Berlin 4
Biên Hòa 4
Florence 4
Guayaquil 4
Haiphong 4
Hải Dương 4
Manchester 4
Orem 4
Palermo 4
Phoenix 4
Pune 4
Quito 4
Recife 4
Redwood City 4
Seoul 4
Turin 4
Wuhan 4
Ahmedabad 3
Alessandria 3
Baghdad 3
Belo Horizonte 3
Bern 3
Caracas 3
Chengdu 3
Curitiba 3
Dongyang 3
Jakarta 3
Jeddah 3
Kemerovo 3
Lariano 3
Medellín 3
Munich 3
Natal 3
New Delhi 3
Porto Alegre 3
Rio de Janeiro 3
Totale 3.984
Nome #
4-Aminopyridine derivatives with anticholinesterase and antiamnesic activity 366
'Prototypical' proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting 107
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis 98
GABAergic signaling and connectivity on Purkinje cells are impaired in experimental autoimmune encephalomyelitis 86
Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis 86
A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum 83
Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis 81
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis 78
Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis 77
Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome 74
TNF-α-mediated anxiety in a mouse model of multiple sclerosis 72
A Dynamic Splicing Program Ensures Proper Synaptic Connections in the Developing Cerebellum 72
Behavioral and electrophysiological effects of endocannabinoid and dopaminergic systems on salient stimuli 71
Caffeine drinking potentiates cannabinoid transmission in the striatum: interaction with stress effects 71
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 71
Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA 71
Impaired striatal GABA transmission in experimental autoimmune encephalomyelitis 70
Before or after does it matter? Different protocols of environmental enrichment differently influence motor, synaptic and structural deficits of cerebellar origin 70
Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis 69
Re-Examining the Role of TNF in MS Pathogenesis and Therapy 69
Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis. 68
Il-1β Dependent Cerebellar Synaptopathy in a Mouse Mode of Multiple Sclerosis 68
Linking synaptopathy and gray matter damage in multiple sclerosis 67
Adaptations of striatal endocannabinoid system during stress 67
Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis 66
Peripheral T cells from multiple sclerosis patients trigger synaptotoxic alterations in central neurons 65
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients 65
Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis 64
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 64
Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum 63
Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions 63
Interleukin-1β promotes long-term potentiation in patients with multiple sclerosis 63
Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter 63
Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum 63
Abnormal activity of the Na/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis 62
Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis 61
Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis 61
Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis 61
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis 60
Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum 60
Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis 60
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis 60
Obesity worsens central inflammation and disability in multiple sclerosis 60
Interleukin-1β alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis 59
Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity 59
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum 59
MiR-142-3p is a key regulator of IL-1β-dependent synaptopathy in neuroinflammation 58
Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination 58
Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis 58
Transient Receptor Potential Vanilloid 1 Modulates Central Inflammation in Multiple Sclerosis 57
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition 56
Adaptations of glutamatergic synapses in the striatum contribute to recovery from cerebellar damage 56
Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis 56
The interplay between inflammatory cytokines and the endocannabinoid system in the regulation of synaptic transmission 55
Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation 55
Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo-controlled study 54
Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum 54
TRPV1 channels facilitate glutamate transmission in the striatum 54
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis 54
Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis 53
Interleukin-1β causes anxiety by interacting with the endocannabinoid system 52
Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis 52
Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis 52
BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis 51
Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis 50
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis 49
Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity 49
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis 49
Cerebellar control of cortico-striatal LTD 48
Differences in spontaneously avoiding or approaching mice reflect differences in CB1-mediated signaling of dorsal striatal transmission 47
Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake 47
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis 47
Genetic regulation of IL-8 influences disease presentation of multiple sclerosis 47
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis 44
An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple Sclerosis 44
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis 44
Lipid rafts regulate 2-arachidonoylglycerol metabolism and physiological activity in the striatum 44
Transient receptor potential vanilloid 1 channels control acetylcholine/2-arachidonoylglicerol coupling in the striatum 44
Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis 44
Preventive exercise and physical rehabilitation promote long‐term potentiation‐like plasticity expression in patients with multiple sclerosis 44
Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis 43
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 43
Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis 42
Effects of caffeine on striatal neurotransmission: focus on cannabinoid CB1 receptors 42
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis 42
Interleukin 6 SNP rs1818879 Regulates Radiological and Inflammatory Activity in Multiple Sclerosis 39
Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis 38
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis 37
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis 36
Electrophysiology of Endocannabinoid Signaling 36
Special Issue Title: The neuroimmune crosstalk in mood disturbances of neurological and psychiatric diseases 32
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis 31
Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation 30
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis 30
Interaction between miR-142-3p and BDNF Val/Met Polymorphism Regulates Multiple Sclerosis Severity 28
Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression 28
Low-contrast visual acuity test is associated with central inflammation and predicts disability development in newly diagnosed multiple sclerosis patients 25
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 17
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis 17
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis 14
Totale 5.849
Categoria #
all - tutte 48.255
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.255


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021439 0 0 0 0 0 0 0 0 0 0 403 36
2021/2022871 2 222 232 4 6 8 34 92 20 226 19 6
2022/2023306 179 4 4 19 8 14 0 9 10 19 23 17
2023/2024226 4 6 8 41 6 14 1 12 0 37 0 97
2024/20251.002 50 160 103 56 37 145 65 48 145 22 39 132
2025/20262.623 155 248 479 199 268 255 349 247 142 275 6 0
Totale 5.863